Thank you for visiting our website. We are complying with the State of California "Safe at Home" order and are not fully staffing our office in San Bernardino. We have employees working from home to answer your questions and our Consultants are still on line. We will still be conducting webinars. Please contact us at or leave a voicemail at (800) 399-6565. We will be respond to your inquiries as soon as possible.

Step therapy: Where do we stand? – Retina Specialist

Answers to questions that linger since Medicare Advantage organizations started implementation for anti-VEGF treatments.

In August 2018, the Centers for Medicare and Medicaid Services  announced plans to institute step therapy for some Medicare beneficiaries enrolled in Medicare replacement plans, also known as Medicare Advantage plans. Historically, step therapy was only used to control costs within private insurance plans. CMS touted this step therapy rule as a cost-saving measure with little downside to most patients.

This article was published in Retina Specialist, which is written by Ellen R. Adams, MBA. To view the entire article in Retina Specialist, click on the link below:

Related Posts

Website by MIC